BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 16505029)

  • 1. Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost.
    Oh DJ; Martin JL; Williams AJ; Peck RE; Pokorny C; Russell P; Birk DE; Rhee DJ
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):953-63. PubMed ID: 16505029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of latanoprost on the expression of matrix metalloproteinases and their tissue inhibitors in human trabecular meshwork cells.
    Oh DJ; Martin JL; Williams AJ; Russell P; Birk DE; Rhee DJ
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3887-95. PubMed ID: 16936101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of alpha2-adrenergic receptors and effect of brimonidine on matrix metalloproteinases and their inhibitors in human ciliary body.
    Ooi YH; Oh DJ; Rhee DJ
    Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4237-43. PubMed ID: 19324857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latanoprost's effects on TIMP-1 and TIMP-2 expression in human ciliary muscle cells.
    Anthony TL; Lindsey JD; Weinreb RN
    Invest Ophthalmol Vis Sci; 2002 Dec; 43(12):3705-11. PubMed ID: 12454040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metalloproteinase gene transcription in human ciliary muscle cells with latanoprost.
    Weinreb RN; Lindsey JD
    Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):716-22. PubMed ID: 11867589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin FP agonists alter metalloproteinase gene expression in sclera.
    Weinreb RN; Lindsey JD; Marchenko G; Marchenko N; Angert M; Strongin A
    Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4368-77. PubMed ID: 15557445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of latanoprost acid and pilocarpine on cultured rabbit ciliary muscle cells.
    Zhong Y; Gao J; Ye W; Huang P; Cheng Y; Jiao Q
    Ophthalmic Res; 2007; 39(4):232-40. PubMed ID: 17622744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis pattern of matrix metalloproteinases (MMPs) and inhibitors (TIMPs) in human explant organ cultures after treatment with latanoprost and dexamethasone.
    el-Shabrawi Y; Eckhardt M; Berghold A; Faulborn J; Auboeck L; Mangge H; Ardjomand N
    Eye (Lond); 2000 Jun; 14 ( Pt 3A)():375-83. PubMed ID: 11027004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of bimatoprost, latanoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human ciliary body smooth muscle cells.
    Ooi YH; Oh DJ; Rhee DJ
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5259-65. PubMed ID: 19443729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latanoprost induces matrix metalloproteinase-1 expression in human nonpigmented ciliary epithelial cells through a cyclooxygenase-2-dependent mechanism.
    Hinz B; Rösch S; Ramer R; Tamm ER; Brune K
    FASEB J; 2005 Nov; 19(13):1929-31. PubMed ID: 16076963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultraviolet radiation and the role of matrix metalloproteinases in the pathogenesis of ocular surface squamous neoplasia.
    Ng J; Coroneo MT; Wakefield D; Di Girolamo N
    Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5295-306. PubMed ID: 18641285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of latanoprost and timolol on the histopathology of the human conjunctiva.
    Terai N; Schlötzer-Schrehardt U; Lampel J; Böhm AG; Rummelt C; Schmidt E; Pillunat LE
    Br J Ophthalmol; 2009 Feb; 93(2):219-24. PubMed ID: 18971237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids.
    Ulrich D; Ulrich F; Unglaub F; Piatkowski A; Pallua N
    J Plast Reconstr Aesthet Surg; 2010 Jun; 63(6):1015-21. PubMed ID: 19464975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases.
    Yamada H; Yoneda M; Gosho M; Kato T; Zako M
    BMC Ophthalmol; 2016 Mar; 16():26. PubMed ID: 26956170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
    Voland P; Besig S; Rad R; Braun T; Baur DM; Perren A; Langer R; Höfler H; Prinz C
    Neuroendocrinology; 2009; 89(1):66-78. PubMed ID: 18708724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latanoprost stimulates secretion of matrix metalloproteinases in tenon fibroblasts both in vitro and in vivo.
    Mietz H; Esser JM; Welsandt G; Kociok N; Hueber A; Joussen A; Esser P; Krieglstein GK
    Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5182-8. PubMed ID: 14638715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time profiles of the expression of metalloproteinases, tissue inhibitors of metalloproteases, cytokines and collagens in hamsters infected with Opisthorchis viverrini with special reference to peribiliary fibrosis and liver injury.
    Prakobwong S; Pinlaor S; Yongvanit P; Sithithaworn P; Pairojkul C; Hiraku Y
    Int J Parasitol; 2009 Jun; 39(7):825-35. PubMed ID: 19168069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell and agonist-specific regulation of genes for matrix metalloproteinases and their tissue inhibitors by primary glial cells.
    Crocker SJ; Milner R; Pham-Mitchell N; Campbell IL
    J Neurochem; 2006 Aug; 98(3):812-23. PubMed ID: 16893421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of interleukin-1beta and dexamethasone on the expression of matrix metalloprotease mRNA by trabecular cells exposed to elevated hydrostatic pressure.
    Ehrich D; Tripathi B; Tripathi R; Duncker G
    Acta Ophthalmol Scand; 2005 Feb; 83(1):104-8. PubMed ID: 15715567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mRNA expression profile of matrix metalloproteinases and their tissue inhibitors in malignant and non-malignant prostatic tissue.
    Lichtinghagen R; Musholt PB; Stephan C; Lein M; Kristiansen G; Hauptmann S; Rudolph B; Schnorr D; Loening SA; Jung K
    Anticancer Res; 2003; 23(3B):2617-24. PubMed ID: 12894549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.